Patient-Centered Outcomes in Bladder Cancer
- PMID: 30370443
- DOI: 10.1007/s11934-018-0858-0
Patient-Centered Outcomes in Bladder Cancer
Abstract
Purpose of review: To summarize current knowledge on patient-prioritized outcomes for their bladder cancer care.
Recent findings: Patient-centered outcomes research seeks to help patients identify the right treatment for the right patient at the right time in their care. As such, patient-centered outcomes research relies on studying a treatment's impact on patient-centered outcomes. Some outcomes, like survival, are commonly prioritized by patients and by clinical experts. Patients often place greater emphasis than experts on quality of life outcomes. Thus, many patient-centered outcomes are also patient-reported outcomes. Unique domains that are often prioritized by patients, but overlooked by experts, include the costs and financial impact of care, anxiety, and depression related to a health condition, and the impact of a condition or its treatment on a caregiver or loved one. Patient-centered outcomes are realizing greater recognition for their innate importance and potential to augment the impact of research studies. Although patient-centered outcomes are often patient-reported outcomes, this is not universal. Unique to bladder cancer, the availability of a research-oriented Patient Survey Network intended to identify research questions that are important to patients may be an opportunity to broadly solicit input on patient-centered outcomes for bladder cancer research questions.
Keywords: Bladder cancer; Health outcomes; Patient-centered outcomes research; Quality of life.
Similar articles
-
The burden of bladder cancer care: direct and indirect costs.Curr Opin Urol. 2014 Sep;24(5):487-91. doi: 10.1097/MOU.0000000000000078. Curr Opin Urol. 2014. PMID: 24887047 Review.
-
Combined modality treatment with selective bladder conservation for invasive bladder cancer: long-term tolerance in the female patient.Cancer J Sci Am. 1996 Mar-Apr;2(2):79-84. Cancer J Sci Am. 1996. PMID: 9166504 Clinical Trial.
-
Assessment of content validity for patient-reported outcome measures used in patients with non-muscle invasive bladder cancer: a systematic review.Support Care Cancer. 2018 Apr;26(4):1061-1076. doi: 10.1007/s00520-018-4058-8. Epub 2018 Feb 1. Support Care Cancer. 2018. PMID: 29392479
-
Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey.Urology. 2005 Feb;65(2):290-4. doi: 10.1016/j.urology.2004.09.050. Urology. 2005. PMID: 15708040
-
A conceptual framework for patient-reported outcomes in non-muscle invasive bladder cancer.Support Care Cancer. 2017 Oct;25(10):3095-3102. doi: 10.1007/s00520-017-3717-5. Epub 2017 Apr 27. Support Care Cancer. 2017. PMID: 28451912
Cited by
-
People-Oriented Nursing Mode on the Negative Emotions and Psychological Status of Patients with Bladder Cancer.Iran J Public Health. 2024 May;53(5):1087-1095. doi: 10.18502/ijph.v53i5.15590. Iran J Public Health. 2024. PMID: 38912154 Free PMC article.
-
Patient-centered outcomes and outcome measurements for people aged 65 years and older-a scoping review.BMC Geriatr. 2024 Jun 18;24(1):528. doi: 10.1186/s12877-024-05134-7. BMC Geriatr. 2024. PMID: 38890618 Free PMC article.
-
Membrane-associated RING-CH 7 inhibits stem-like capacities of bladder cancer cells by interacting with nucleotide-binding oligomerization domain containing 1.Cell Biosci. 2024 Mar 10;14(1):32. doi: 10.1186/s13578-024-01210-y. Cell Biosci. 2024. PMID: 38462600 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials